CRDL Cardiol Therapeutics Forecast, Technical & Fundamental Analysis
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease... Show more
CRDL is expected to report earnings to fall 6.56% to -6 cents per share on August 17
Q2'26
Est.
$-0.07
Q1'26
Est.
$-0.07
Q4'25
Beat
by $0.03
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.03
The last earnings report on May 11 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 288.53K shares outstanding, the current market capitalization sits at 120.44M.
A.I.dvisor tells us that CRDL and ACB have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and ACB's prices will move in lockstep.
Momentum Indicator for CRDL turns negative, indicating new downward trend
CRDL saw its Momentum Indicator move below the 0 level on May 26, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned negative. In of the 99 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
CRDL moved below its 50-day moving average on May 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRDL crossed bearishly below the 50-day moving average on May 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRDL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CRDL entered a downward trend on June 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRDL advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .
CRDL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.854) is normal, around the industry mean (144.130). P/E Ratio (0.000) is within average values for comparable stocks, (97.681). CRDL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.601). CRDL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (0.000) is also within normal values, averaging (95.029).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRDL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRDL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
